Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen for unscheduled bleeding in LNG-IUS users
NCT02824224Phase 4Completed
- Sponsor
- Oregon Health & Science University
- Start
- Sep 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tamoxifen in metrorrhagia, Menorrhagia, sponsored by Oregon Health & Science University. Started Sep 2016; status: completed.
02
Drugs
tamoxifen
03
Conditions
metrorrhagiaMenorrhagia
Beyond the preview
Go deeper on NCT02824224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02824224.